Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista colombiana de Gastroenterología
Print version ISSN 0120-9957On-line version ISSN 2500-7440
Abstract
OLIVEROS, Ricardo; SIERRA-PRIETO, Jonathan; BONILLA-GONZALEZ, Carlos and MESA-LOPEZ DE MESA, Jorge Andrés. Importance of HER2 status determination in advanced gastric cancer: A case study. Rev. colomb. Gastroenterol. [online]. 2021, vol.36, suppl.1, pp.2-10. Epub Feb 18, 2022. ISSN 0120-9957. https://doi.org/10.22516/25007440.503.
Advanced gastric cancer (AGC) is an entity that encompasses two distinct clinical situations: locally advanced unresectable gastric cancer and metastatic disease, with chemotherapy as the standard treatment. HER2 overexpression can occur in 9% to 38% of the cases with this disease and has been the first predictive biomarker used for trastuzumab-targeted therapy in patients with advanced gastric and gastroesophageal tumors. This article presents a patient with AGC and positive HER2 treated with conventional chemotherapy plus trastuzumab as targeted therapy with adequate clinical response.
Keywords : Advanced gastric cancer; Treatment; Trastuzumab; HER2.